Faced with a stagnant stock price that has hovered in the $3 to $5 range over the past year and investors whose patience may be "wearing a bit thin," Harvard Bioscience held a conference call last week to provide a more complete picture of its two major business segments and how it intends to grow them.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Technology Review reports that 2017 was the year of consumer genetic testing and that it could spur new analysis companies.

A phylogenetic analysis indicates two venomous Australian spiders are more closely related than thought, the International Business Times reports.

In Science this week: CRISPR-based approach for recording cellular events, and more.

A new company says it will analyze customers' genes to find them a suitable date, though Smithsonian magazine says the science behind it might be shaky.